可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] 臧益民, 臧伟进, 朱妙章. 心脏与内分泌 [J] . 心脏杂志, 2001, 13(6):557-563.
[2] Kone BC. Molecular biology of natriuretic peptides and nitric oxide synthases [J] . Cardiovasc Res, 2001, 51(3):439-441.
[3] Suzuki T, Yamazaki T, Yazaki Y. The role of the natriuretic peptides in the cardiovascular system [J] . Cardiovasc Res, 2001,51(3):389-394.
[4] Kalra PR, Tigas S. Regulation of lipolysis: natriuretic peptides and the development of cachexia [J] . Int J Cardiol, 2002, 85(1):125-132.
[5] 饶春明, 王军志, 赵阳, 等. 重组人脑利钠肽质量标准与检定方法研究 [J] . 药物分析杂志, 2002, 22(5):346.
[6] Levin ER, Gardner DG, Samson WK. natriuretic peptides [J] . N Engl J Med, 1998, 339(5):321-328.
[7] Nagaya N, Goto Y, Nishikimi T, et al. Sustained eleation of plasma brain matriuretic peptide levels associated with progressive ventricular remodeling after acute myocardial infarction [J] . Clin Sci(Coch), 1999, 96:129-136.
[8] Silberbach M, Roberts CTJr. Natriuretic peptide signalling: molecular and cellular pathways to growth regulation [J] . Cell Signal, 2001, 13(4):221-231.
[9] Redfield MM, Rodeheffer RJ, Jacobsen SJ, et al. Plasma brain natriuretic peptide concentration: impact of age and gender [J] . J Am Coll Cardiol, 2002, 40(5):976-982.4.
[10] Maisel A. B-type natriuretic peptide in the diagnosis and management of congestive heart failuer [J] . Cardiol Clin, 2001, 19(4):557-571.
[11] 卢春燕, 余敏, 曾智. B型钠尿肽及其在临床中的应用 [J] . 心脏杂志, 2002, 15(2):172-174.
[12] McCullough PA, Nowak RM, McCord J, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study [J] . Circulation, 2002, 106(4):416-422.
[13] Paul R. Kalra PR, Allan D. Struthers: More evidence for bedside BNP in heart failure assessment [J] . Int J Cardiol, 2002, 86:149-150.
[14] Luchner A, Brockel U, Muscholl M, et al. Gender-specific differences of cardiac remodeling in subjects with left ventricular dysfunction: apopulation-based study [J] . Cardiovasc Res, 2002, 53(3):720-727.
[15] Maisel AS, Koon J, Krishnaswamy P, et al. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction [J] . Am Heart J, 2001, 141(3):367-374.
[16] Nakamura M, Endo H, Vasu M, et al. Value of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese population [J] . Heart, 2002, 87(2):131-135.
[17] Kalra PR, Anker SD, Coats AJ. Water and sodium regulation in chronic heart failure: the role of natriuretic peptides and vasopressin [J] . Cardiovasc Res, 2001, 51(3):495-509.
[18]Kazanegera R, Cheng V, Garcia A, et al. A rapidtest for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: apilot study [J] . J Card Fail, 2001, 7(1):21-29.
[19] Bettencourt P, Ferreira A, Pardaloliveira N, et al. Clinical significance of brain natriuretic peptide in patients with post myocardial infarction [J] . Clin Cardiol, 2000, 23(12):921-927.
[20] Klemola R, Tikkanen I, Vuolteenaho O, et al. Plasma and pericardial fluid natriuretic peptide levels in post infarction ventricular dysfunction [J] . J Heart Fail, 2001, 3(1):21-26.
[21] Elkayam U, Akhter MW, Tummala P, et al. Nesiritide: a new durg for the treatment of decompensated heart failure [J] . J Cardiovasc Pharmacol Ther, 2002, 7(3):181-194.
[22] Mills RM, Hobbs RE, Young JB. "BNP" for heart failure: role of nesiritide in cardiovascular therapeutics [J] . Congest Heart Fail, 2002, 8(5):270-273.
[23] 张智. 尿中中性肽链内切酶与肾小管损伤 [J] . 临床肾脏杂志, 2002, 2(2):84.
[24] 李能刚, 徐进宜, 吴晓明. 血管紧张素转化酶和中性肽链内切酶的双重抑制剂 [J] . 药学进展, 2000, 24(3):133-135.[25] 陶则伟. 心衰学说的发展与防治 [J] . 心血管病学进展, 2003, 24(1):67-70.